Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review.

ABSTRACT: Studies using arginine-glycine-aspartate (RGD)-PET agents in cardiovascular diseases have been recently published. The aim of this systematic review was to perform an updated, evidence-based summary about the role of RGD-based PET agents in patients with cardiovascular diseases to better address future research in this setting. Original articles within the field of interest reporting the role of RGD-based PET agents in patients with cardiovascular diseases were eligible for inclusion in this systematic review. A systematic literature search of PubMed/MEDLINE and Cochrane library databases was performed until October 26, 2021. Literature shows an increasing role of RGD-based PET agents in patients with cardiovascular diseases. Overall, two main topics emerged: the infarcted myocardium and a

SUBMITTER: Dietz M 

PROVIDER: S-EPMC9120643 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature